Share on

Europe Flow Cytometry Market Research Report – Segmented By Technology, By Product, By Application, By End-users & By Country(UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2023 to 2028)

Published: March, 2023
ID: 2106
Pages: 137
Formats: report pdf report excel report power bi report ppt

Europe Flow Cytometry Market Size (2023 to 2028)

The size of the Flow Cytometry market in Europe has been estimated at USD 1388.97 Million in 2023. It is projected to reach USD 2226.80 Million by 2028, at a CAGR of 9.9% during the forecast period.

Flow cytometry is widely utilized in cancer and immunodeficiency diagnosis. The flow cytometry market in Europe is projected to be driven by the rising prevalence of various diseases throughout the forecast period. The European Flow cytometry market is further projected to be fuelled by the increasing prevalence of targeted diseases. Also, the rising awareness towards health concerns and increasing chromosomal defects are expected to influence the market growth.

In addition, the proliferation of chronic and contagious diseases and the recent global pandemic is uplifting the market growth during the forecast period. The introduction of new flow cytometry technologies is expected to enhance the market growth. Furthermore, in the forecast period, product innovation in diagnostic reagents, extensive applications of flow cytometry in clinical research, stem cell research, and increasing technical improvement in the area of flow cytometry is expected to accelerate the market's growth. 

The regional market players play an essential part in developing technologies for innovative instruments to enhance customer satisfaction, which has shown to help lead the fastest market growth and obtain a prominent share in the coming years. Growing awareness about a cancer diagnosis will likely create attractive growth opportunities for the flow cytometry market during the projected period. Furthermore, the adverse effects of chemotherapy and radiation therapy in cancer treatment have increased physicians' preference for autologous and allogeneic stem cell treatments, which is expected to boost the market's growth.

However, the lack of awareness among the potential users and the dearth of skilled professionals are expected to hinder the market growth. Also, the high cost associated with the instruments and reagents is expected to impede market growth. 

This research report on the European Flow Cytometry market has been segmented and sub-segmented into the following categories:

By Technology: 

  • Cell-based
  • Bead-based

By Product: 

  • Reagents & Consumables
  • Flow Cytometry Instruments

By Application: 

  • Research
  • Clinical
  • Industrial

By End-users: 

  • Commercial Organizations
  • Research Institutes
  • Clinical Testing Labs

By Country: 

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Regionally, the European flow cytometry market held the second-largest share in the global market during the forecast period. Advances have mostly influenced the use of flow cytometry in immunology and other areas of cancer research. Although end-users, academics, and research institutes account for the majority of the market and are growing at the fastest rate due to flow cytometry, researchers are aided in various ways, including the rapid examination of various individual cell types within a population of cells suspended in fluid. The most well-known use of flow cytometry is immunophenotyping or the classification of cell subpopulations based on differentiation antigens. The major growth contributors in the region are UK, Germany, and France. 

The German flow cytometry market accounted for the largest share of the flow cytometry market and likely continue its growth throughout the forecast period. The market growth is attributed to the availability of advanced technology and increasing healthcare spending. However, increasing the focus of the key market players for adopting effective strategies and policies to gain a competitive advantage over the marketplace is expected to expand the market growth.

On the other hand, the UK flow cytometry market is likely to anticipate the highest share in the flow cytometry market and expand the European regional market growth. The increasing prevalence of diseases such as cancer and HIV are majorly driving the market growth. Furthermore, high-performance flow cytometers and high-speed cell sorters are widely used in research fields such as HIV, cancer, stem cell, and drug development, propelling the market's growth. As a result, it is predicted that the flow cytometry market is predicted to grow more effectively throughout the forecasted period.


A few of the companies playing a significant role in the Europe Flow Cytometry Market profiled in this report are Becton, Dickinson and Company, Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Merck KGaA, Sysmex Partec GmbH, Luminex Corporation, Miltenyi Biotec GmbH, Bio-Rad Laboratories, Inc., Sony Biotechnology, Life Technologies Corporation Inc., EMD Millipore Corporation, Miltenyi Biotec, Thermo Fischer Scientific, Agilent Technologies, Inc. and Affymetix Inc.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us:

Click for Request Sample